A detailed history of Pfg Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 32,055 shares of ABBV stock, worth $5.36 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
32,055
Previous 15,066 112.76%
Holding current value
$5.36 Million
Previous $2.33 Billion 150.01%
% of portfolio
0.35%
Previous 0.43%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $2.72 Million - $3.09 Million
16,989 Added 112.76%
32,055 $5.84 Billion
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $152,736 - $172,016
1,110 Added 7.95%
15,066 $2.33 Billion
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $67,062 - $77,634
-502 Reduced 3.47%
13,956 $2.08 Billion
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $203,535 - $253,286
1,536 Added 11.89%
14,458 $1.95 Billion
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $1.87 Million - $2.15 Million
12,922 New
12,922 $2.06 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.